Profile data is unavailable for this security.
About the company
TERUMO CORPORATION is a manufacturer of medical supplies. The Company operates in three segments. The Cardiac and Vascular Company segment is engaged in the manufacture of catheter system and cardiopulmonary system products, the import of the cardiopulmonary systems and artificial blood vessels, as well as the sale of products mainly to hospitals and clinics nationwide through agents. The Hospital Company segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The segment is also engaged in the manufacture and sale of healthcare related products. The Blood System Company segment is engaged in the manufacture and sale of blood transfusion-related products.
- Revenue in JPY (TTM)964.80bn
- Net income in JPY117.72bn
- Incorporated1921
- Employees30.59k
- LocationTerumo Corp2-44-1, HatagayaSHIBUYA-KU 151-0072JapanJPN
- Phone+81 333748111
- Fax+81 333748399
- Websitehttps://www.terumo.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| QuantumPharm Inc | 3.96bn | -50.95bn | 813.28bn | 783.00 | -- | 9.82 | -- | 205.58 | -0.8186 | -0.8186 | 0.0636 | 1.33 | -- | -- | -- | 276,532.00 | -- | -- | -- | -- | -- | -- | -1,280.46 | -- | -- | -- | 0.038 | -- | 30.80 | -- | -33.08 | -- | -- | -- |
| Shanghai United Img Hlthcare Co Ltd | 230.33bn | 39.88bn | 1.61tn | 7.44k | 40.31 | 4.08 | -- | 7.01 | 2.42 | 2.42 | 13.96 | 23.92 | 0.4476 | 1.37 | 3.17 | 1,542,057.00 | 7.73 | -- | 10.12 | -- | 48.71 | -- | 17.28 | -- | 2.50 | -- | 0.0206 | -- | 23.52 | -- | 19.21 | -- | -- | -- |
| Pro Medicus Limited | 16.00bn | 7.97bn | 1.69tn | 79.00 | 212.43 | 93.46 | 192.30 | 105.56 | 0.7909 | 0.7909 | 1.59 | 1.80 | 0.7239 | 5.79 | 3.72 | -- | 36.03 | 32.19 | 42.01 | 37.84 | 99.82 | 99.58 | 49.78 | 47.15 | 5.98 | 104.83 | 0.0109 | 33.66 | 30.63 | 27.00 | 36.52 | 34.05 | -2.38 | 37.97 |
| Sysmex Corp | 478.10bn | 52.05bn | 1.78tn | 10.04k | 33.90 | 3.93 | 19.84 | 3.71 | 83.23 | 83.23 | 764.54 | 718.49 | 0.8231 | 2.66 | 3.61 | 47,610,440.00 | 8.99 | 8.92 | 10.90 | 11.29 | 52.73 | 52.27 | 10.92 | 11.19 | 2.40 | 24.54 | 0.1147 | 39.12 | 12.43 | 9.47 | 8.42 | 3.79 | 11.61 | 3.71 |
| Cochlear Ltd | 215.08bn | 34.33bn | 1.81tn | 5.00k | 52.83 | 10.21 | 42.53 | 8.40 | 5.43 | 5.43 | 34.02 | 28.10 | 0.8414 | 1.54 | 4.82 | 447,120.00 | 13.43 | 8.55 | 17.39 | 11.15 | 75.84 | 75.05 | 15.96 | 11.98 | 1.68 | -- | 0.1169 | 91.14 | 15.47 | 9.40 | 18.70 | 5.22 | -4.76 | 4.44 |
| Fisher & Paykel Healthcare Corporatn Ltd | 153.53bn | 11.68bn | 1.96tn | 7.14k | 167.83 | 12.62 | 90.28 | 12.79 | 0.2266 | 0.2266 | 2.97 | 3.01 | 0.777 | 2.04 | 7.33 | 244,055.50 | 5.91 | 16.43 | 6.96 | 19.83 | 59.93 | 62.09 | 7.61 | 19.07 | 0.9987 | 18.03 | 0.0971 | 49.48 | 10.23 | 10.24 | -47.02 | -8.72 | 20.52 | 12.29 |
| Olympus Corp | 963.31bn | 27.96bn | 3.00tn | 28.84k | 103.20 | 3.75 | 31.61 | 3.11 | 24.65 | 14.91 | 807.19 | 677.69 | 0.6014 | 1.74 | 5.49 | 33,404,120.00 | 1.77 | 6.38 | 2.39 | 9.06 | 66.86 | 65.88 | 2.93 | 9.91 | 1.30 | 14.30 | 0.2437 | 21.73 | 6.16 | 3.35 | -80.69 | 26.71 | 1.01 | 19.14 |
| Terumo Corp | 964.80bn | 117.72bn | 3.91tn | 30.59k | 33.12 | 2.74 | 19.79 | 4.05 | 79.16 | 79.16 | 648.76 | 955.29 | 0.5451 | 1.59 | 5.64 | 31,538,820.00 | 6.65 | 6.25 | 7.95 | 7.37 | 52.74 | 52.50 | 12.20 | 12.11 | 1.72 | -- | 0.1207 | 29.37 | 12.39 | 8.99 | 19.09 | 6.01 | 7.70 | 10.26 |
| Hoya Corp | 794.10bn | 190.32bn | 6.73tn | 35.70k | 35.38 | 6.62 | 28.31 | 8.47 | 541.86 | 541.86 | 2,261.00 | 2,896.47 | 0.6725 | 0.9363 | 5.16 | 22,242,310.00 | 16.19 | 16.21 | 18.87 | 18.87 | 85.88 | 85.10 | 24.08 | 23.13 | 4.43 | -- | 0.0306 | 24.56 | 5.39 | 6.15 | 7.55 | 8.23 | 9.02 | 4.10 |
Data as of Sep 18 2024. Currency figures normalised to Terumo Corp's reporting currency: Japanese Yen JPY
30.41%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 31 Mar 2024 | 122.48m | 8.22% |
| Nikko Asset Management Co., Ltd.as of 06 Sep 2024 | 55.58m | 3.73% |
| Daiwa Asset Management Co. Ltd.as of 30 Aug 2024 | 52.45m | 3.52% |
| The Vanguard Group, Inc.as of 04 Sep 2024 | 51.60m | 3.46% |
| Asset Management One Co., Ltd.as of 14 Apr 2023 | 43.13m | 2.89% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 22 Jul 2024 | 29.17m | 1.96% |
| BlackRock Fund Advisorsas of 05 Sep 2024 | 27.17m | 1.82% |
| Schroder Investment Management Ltd.as of 31 Jul 2024 | 25.38m | 1.70% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 25.00m | 1.68% |
| National Mutual Insurance Fed. of Agricultural Cooperativesas of 30 Sep 2023 | 21.31m | 1.43% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
